Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
WSJ PRICE TARGET CYDY $4.00
"leronlimab | The Rio Times" https://riotimesonline.com/brazil-news/tag/leronlimab/
Another scenario is the Brazil trials DO pan out AND the HIV BLA is back on track within a few months. This scenario is far more likely.
200,000 vials set aside for the Philippines... and now there is a purchase order with the Philippines... do the math $240 million
CytoDyn is a revenue producing company. Read the PR again
So your way of being objective is to plug your ears close your eyes and say this isn't happening?
When trial started in Brazil PR hits expect CYDY to move towards $3
Please provide the details on CYDY after the Memorial Day weekend
Purchase Order
"a fairly substantial portion improved"
Dr Yang speaking of the patients he treated with Leronlimab. This is consistent with every doctor that has treated patients with Leronlimab.
All of this is irrelevant from an investment standpoint with CYDY. The number of covid-19 cases won't stop approval for Leronlimab. After Leronlimab receives first approval it will stabilize CytoDyn as a pharma company and start revenue. COVID-19 will be here indefinitely and approval for Leronlimab will open the door for other ARDS.
That's the exact short talking point in May of 2020, COVID-19 is still here and changing, it's now killing younger healthy people.
LL is very effective for Covid, the trial in Brazil with 4 doses for critical patients will show that. Smart move for CytoDyn to continue CD12 in Brazil where it can be filled quickly.
Macleods Pharmaceuticals...Academic Research Organization (ARO) - Albert Einstein Israelite Hospital (AEIH) in São Paulo, Brazil ....multiple hospitals in Philippines stocking Leronlimab
The FDA scientist were informed 4 doses of Leronlimab will save lives. Apparently they made the decision they don't care.
Don't be scared don, it's going to save alot of lives when they sell Leronlimab in India, you should be excited about it!
So you're conclusion is Macleods will be selling Leronlimab in multiple different countries not just India and Brazil. Good to know
"Other news to note for May 13, 2021 | 2021-05-13 | BioWorld" https://www.bioworld.com/articles/507066-other-news-to-note-for-may-13-2021
If you're going to post a fake doctored search screen at least get his race correct. Nader's a white guy??
I heard NP was spotted changing lanes..WITHOUT USING HIS SIGNAL!!
That part of the interview really got my attention, also caught the attention of Cito Beltran and when he pressed NP for more info on India NP responded they are a public company and must make an official announcement. We may see major news come from India before Philippines.
Why did HGEN dump after they released that preprint? Is HGEN a scam and the market detected this after seeing the data?
So you're saying there will be a buyout this week?!! Trading will be halted for the buyout? Or CYDY PR's news of EUA in India this week and trading is halted as it's gapping up to $50? My bet would be on the EUA, when asked about India NP said they were in talks with them but when pressed on the subject he couldn't answer because CytoDyn is a public company and they would need to PR an announcement.
Here's a short version of the interview today
He can't discuss India right now because they are a public company and must make an announcement. This could be huge!
Why is this stock struggling to break $20? Why are there no buyers? Could this be part of the reason?
The recovery numbers look impressive now that people are being treated with Leronlimab! This is great news!!!